Showing posts with label Active Psoriatic Arthritis Market Trends. Show all posts
Showing posts with label Active Psoriatic Arthritis Market Trends. Show all posts

Wednesday, December 30, 2020

Active Psoriatic Arthritis Market Trend, Research Approach, Data Analysis and Forecast to 2027

 


Market Size – USD 7.15 Billion in 2019, Market Growth – CAGR of 9.2%, Market Trends– Growing Prevalence of Psoriasis

The Global Active Psoriatic ArthritisMarket Report published by Reports and Data is an extensive analysis of the Active Psoriatic Arthritis market and includes a study of several factors that impact the growth of the market. The report further analyzes historical data, current and future market trends, recent technological developments, key competitors, and regional bifurcation. The global Active Psoriatic Arthritis Market was valued at USD 7.15 billion in 2019 and is expected to reach USD 13.64 billion by 2027, at a CAGR of 9.2%.

The report includes an analysis of the COVID-19 impact on the market. The report aims to provide an insightful illustration of the latest market scenario, economic slowdown, social restrictions, and COVID-19 impact on the overall industry. The report provides the impact analysis of the COVID-19 based on different scenarios and includes analysis of potential opportunities post COVID-19, challenges, drivers, and risks.

Get your FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample-form/72

Key participants include: Novartis International AG, Johnson & Johnson Services, AbbVie, AstraZeneca, Amgen, Celgene Corporation, Bristol-Myers Squibb Company, Bausch Health Companies, Eli Lilly and Company and Pfizer among other companies

Product Outlook (Revenue in Million USD; 2017–2027)

  1. Prescriptions
  2. OTC
  3. Other

Drug Class Outlook (Revenue in Million USD; 2017–2027)

  1. Biologics
  2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  3. Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
  4. Other

By Route of Administration (Revenue in Million USD; 2017–2027)

  1. Injectable
  2. Oral
  3. Topical

Regional Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)

North America

  1. U.S.
  2. Canada
  3. Mexico

Europe

  1. UK
  2. Germany
  3. France
  4. BENELUX
  5. Rest of Europe

Asia Pacific

  1. China
  2. Japan
  3. South Korea
  4. Rest of APAC

Latin America

  1. Brazil
  2. Rest of LATAM

MEA

  1. Saudi Arabia
  2. UAE
  3. Rest of MEA

To identify the key trends in the industry and read full summary click on the link: https://www.emergenresearch.com/industry-report/active-psoriatic-arthritis-market

The research provides answers to the following key questions:

  1. What is the expected market size of the Active Psoriatic Arthritis market for the forecast period 2020 - 2027? What will be the growth rate of the industry during the estimated period?
  2. What are the major driving forces shaping the future of the Active Psoriatic Arthritis industry worldwide?
  3. Who are the major vendors in the industry and what are their strategies to reap more profits and reduce costs?
  4. What are the trends from the past and future that are likely to favor the progress of the Active Psoriatic Arthritis industry worldwide?
  5. What are the major threats and challenges that hinder the development of the industry?
  6. What are the opportunities in store for the business owners operating in the market?